173 related articles for article (PubMed ID: 16819541)
1. Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4.
Schimanski CC; Bahre R; Gockel I; Müller A; Frerichs K; Hörner V; Teufel A; Simiantonaki N; Biesterfeld S; Wehler T; Schuler M; Achenbach T; Junginger T; Galle PR; Moehler M
Br J Cancer; 2006 Jul; 95(2):210-7. PubMed ID: 16819541
[TBL] [Abstract][Full Text] [Related]
2. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.
Sutton A; Friand V; Brulé-Donneger S; Chaigneau T; Ziol M; Sainte-Catherine O; Poiré A; Saffar L; Kraemer M; Vassy J; Nahon P; Salzmann JL; Gattegno L; Charnaux N
Mol Cancer Res; 2007 Jan; 5(1):21-33. PubMed ID: 17259344
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptor CCR7 enhances intrahepatic and lymphatic dissemination of human hepatocellular cancer.
Schimanski CC; Bahre R; Gockel I; Junginger T; Simiantonaki N; Biesterfeld S; Achenbach T; Wehler T; Galle PR; Moehler M
Oncol Rep; 2006 Jul; 16(1):109-13. PubMed ID: 16786131
[TBL] [Abstract][Full Text] [Related]
4. Roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in metastasis of hepatocellular carcinoma cells.
Liu H; Pan Z; Li A; Fu S; Lei Y; Sun H; Wu M; Zhou W
Cell Mol Immunol; 2008 Oct; 5(5):373-8. PubMed ID: 18954561
[TBL] [Abstract][Full Text] [Related]
5. Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer.
Schimanski CC; Schwald S; Simiantonaki N; Jayasinghe C; Gönner U; Wilsberg V; Junginger T; Berger MR; Galle PR; Moehler M
Clin Cancer Res; 2005 Mar; 11(5):1743-50. PubMed ID: 15755995
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of stromal cell-derived factor-1 (SDF-1) and CXCR4 ligand receptor system in hepatocellular carcinoma.
Li W; Gomez E; Zhang Z
J Exp Clin Cancer Res; 2007 Dec; 26(4):527-33. PubMed ID: 18365549
[TBL] [Abstract][Full Text] [Related]
7. CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma.
Chen GS; Yu HS; Lan CC; Chow KC; Lin TY; Kok LF; Lu MP; Liu CH; Wu MT
Br J Dermatol; 2006 May; 154(5):910-8. PubMed ID: 16634895
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
[TBL] [Abstract][Full Text] [Related]
9. Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells.
Friand V; Haddad O; Papy-Garcia D; Hlawaty H; Vassy R; Hamma-Kourbali Y; Perret GY; Courty J; Baleux F; Oudar O; Gattegno L; Sutton A; Charnaux N
Glycobiology; 2009 Dec; 19(12):1511-24. PubMed ID: 19717493
[TBL] [Abstract][Full Text] [Related]
10. Functional expression of CXC chemokine recepter-4 mediates the secretion of matrix metalloproteinases from mouse hepatocarcinoma cell lines with different lymphatic metastasis ability.
Chu H; Zhou H; Liu Y; Liu X; Hu Y; Zhang J
Int J Biochem Cell Biol; 2007; 39(1):197-205. PubMed ID: 16973405
[TBL] [Abstract][Full Text] [Related]
11. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor.
Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ
Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346
[TBL] [Abstract][Full Text] [Related]
12. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
Lee HJ; Kim SW; Kim HY; Li S; Yun HJ; Song KS; Kim S; Jo DY
Int J Oncol; 2009 Feb; 34(2):473-80. PubMed ID: 19148483
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma.
Hu F; Miao L; Zhao Y; Xiao YY; Xu Q
Drug Des Devel Ther; 2015; 9():3625-33. PubMed ID: 26203228
[TBL] [Abstract][Full Text] [Related]
14. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression.
Jiang YP; Wu XH; Shi B; Wu WX; Yin GR
Gynecol Oncol; 2006 Oct; 103(1):226-33. PubMed ID: 16631235
[TBL] [Abstract][Full Text] [Related]
15. Overactivation of the TGF-β pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells.
Bertran E; Crosas-Molist E; Sancho P; Caja L; Lopez-Luque J; Navarro E; Egea G; Lastra R; Serrano T; Ramos E; Fabregat I
Hepatology; 2013 Dec; 58(6):2032-44. PubMed ID: 23813475
[TBL] [Abstract][Full Text] [Related]
16. Role of CXCL12 in metastasis of human ovarian cancer.
Jiang YP; Wu XH; Xing HY; DU XY
Chin Med J (Engl); 2007 Jul; 120(14):1251-5. PubMed ID: 17697577
[TBL] [Abstract][Full Text] [Related]
17. [Nuclear accumulation of CXCR4 and overexpressions of VEGF-C and CK19 are associated with a higher risk of lymph node metastasis in hepatocellular carcinoma].
Xiang ZL; Zeng ZC; Tang ZY; Fan J; Sun HC; Wu WZ; Tan YS
Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):344-9. PubMed ID: 20723431
[TBL] [Abstract][Full Text] [Related]
18. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.
Rubie C; Frick VO; Wagner M; Weber C; Kruse B; Kempf K; König J; Rau B; Schilling M
World J Gastroenterol; 2006 Nov; 12(41):6627-33. PubMed ID: 17075975
[TBL] [Abstract][Full Text] [Related]
19. Regional expression of CXCL12/CXCR4 in liver and hepatocellular carcinoma and cell-cycle variation during in vitro differentiation.
Shibuta K; Mori M; Shimoda K; Inoue H; Mitra P; Barnard GF
Jpn J Cancer Res; 2002 Jul; 93(7):789-97. PubMed ID: 12149145
[TBL] [Abstract][Full Text] [Related]
20. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS
J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
